Global Opisthorchiasis Treatment Market, By Treatment (Antibiotic, Anthelmintics, Surgery, Others), Diagnosis (Cholangiography, MRI, Ultrasonography, CT scan, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia, Abdominal pain, Eosinophilia, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Opisthorchiasis Treatment Market
Opisthorchiasis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.70% in the above mentioned forecast period.
Opisthorchiasis is a parasitic helminthiasis infectious disease which is caused by the infection with Opisthorchis viverrini or Opisthorchis felineus. It is transmitted through the consumption of undercooked or infected raw fish. Symptoms of this disease are jaundice, diarrhea, fever, splenomegaly, weight loss, tachycardia, abdominal pain and eosinophilia. It is a fluke’s infection and infects the different parts of the body for instance lungs, liver, gastrointestinal tract and blood vessels.
Rise in the prevalence of opisthorchiasis due to high consumption of raw or undercooked fishes, growing healthcare expenditure, development of treatment options, growing government funding and rising initiatives to spread awareness about the sea food infection are the factors that will expand the opisthorchiasis treatment market.
Rise in the research and development activities and emerging markets will provide beneficial opportunities for the opisthorchiasis treatment market in the forecast period of 2021-2028.
However, high cost of treatment and lack of awareness about parasitic infection are the factors that will hinder the market growth. Complications related with opisthorchiasis such as cholangiocarcinoma, anaemia, pancreatitis, pyogenic cholangitis and intercurrent bacterial infection will further challenge the opisthorchiasis treatment market in the forecast period mentioned above.
This opisthorchiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the opisthorchiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Opisthorchiasis Treatment Market Scope and Market Size
The opisthorchiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the opisthorchiasis treatment market is segmented into antibiotic, anthelmintics, surgery and others. Anthelmintics have been further sub-segmented into albendazole and praziquantel.
- On the basis of diagnosis, the opisthorchiasis treatment market is segmented into cholangiography, MRI, ultrasonography, CT scan and others.
- On the basis of dosage, the opisthorchiasis treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the opisthorchiasis treatment market is segmented into oral, intravenous and others.
- On the basis of symptoms, the opisthorchiasis treatment market is segmented into jaundice, diarrhea, fever, splenomegaly, weight loss, tachycardia, abdominal pain, eosinophilia and others.
- On the basis of end-users, the opisthorchiasis treatment market is segmented into clinic, hospital and others.
The opisthorchiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Opisthorchiasis Treatment Market Country Level Analysis
Opisthorchiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.
The countries covered in the opisthorchiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the opisthorchiasis treatment market due to the presence of major key players, growing investment for R&D activities, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector, rise in the prevalence of opisthorchiasis and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Opisthorchiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Opisthorchiasis Treatment Market Share Analysis
Opisthorchiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to opisthorchiasis treatment market research.
The major players covered in the opisthorchiasis treatment market report are Cipla Inc., Johnson & Johnson Private Limited, Mankind Pharma, Sun Pharmaceutical Industries Ltd., Merck KGaA, Amneal Pharmaceuticals LLC., Boehringer Ingelheim International GmbH., Zoetis, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, , SeQuent, Lasa Supergenerics Ltd., K.A.Malle Pharmaceuticals, LEO BIO-CARE PVT. LTD., Salius Pharma Private Limited., Fredun Group, Hubei Zhongjia-Chem Pharmaceutical Co., Ltd., Ashish Life Science, AdvaCare Pharma, Gonane Pharma, Aarambh life science, F. Hoffmann-La Roche Ltd., and AbbVie Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-